Overview of SARS-CoV-2 genome-encoded proteins
- PMID: 34387838
- PMCID: PMC8362648
- DOI: 10.1007/s11427-021-1964-4
Overview of SARS-CoV-2 genome-encoded proteins
Abstract
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world. SARS-CoV-2 is an enveloped, plus-stranded RNA virus with a single-stranded RNA genome of approximately 30,000 nucleotides. The SARS-CoV-2 genome encodes 29 proteins, including 16 nonstructural, 4 structural and 9 accessory proteins. To date, over 1,228 experimental structures of SARS-CoV-2 proteins have been deposited in the Protein Data Bank (PDB), including 16 protein structures, two functional domain structures of nucleocapsid (N) protein, and scores of complexes. Overall, they exhibit high similarity to SARS-CoV proteins. Here, we summarize the progress of structural and functional research on SARS-CoV-2 proteins. These studies provide structural and functional insights into proteins of SARS-CoV-2, and further elucidate the daedal relationship between different components at the atomic level in the viral life cycle, including attachment to the host cell, viral genome replication and transcription, genome packaging and assembly, and virus release. It is important to understand the structural and functional properties of SARS-CoV-2 proteins as it will facilitate the development of anti-CoV drugs and vaccines to prevent and control the current SARS-CoV-2 pandemic.
Keywords: SARS-CoV-2; biological impact; coronavirus; structural and functional characterization; structure and function-based drug discovery.
© 2022. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Similar articles
-
Structural insights into SARS-CoV-2 proteins.J Mol Biol. 2021 Jan 22;433(2):166725. doi: 10.1016/j.jmb.2020.11.024. Epub 2020 Nov 24. J Mol Biol. 2021. PMID: 33245961 Free PMC article. Review.
-
Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.Biomed Res Int. 2020 Oct 20;2020:7234961. doi: 10.1155/2020/7234961. eCollection 2020. Biomed Res Int. 2020. PMID: 33102591 Free PMC article.
-
Structural biology of SARS-CoV-2 and implications for therapeutic development.Nat Rev Microbiol. 2021 Nov;19(11):685-700. doi: 10.1038/s41579-021-00630-8. Epub 2021 Sep 17. Nat Rev Microbiol. 2021. PMID: 34535791 Free PMC article. Review.
-
Properties of Coronavirus and SARS-CoV-2.Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review.
-
Molecular Characterization of SARS-CoV-2.Curr Mol Med. 2021;21(7):589-595. doi: 10.2174/1566524020999201203213037. Curr Mol Med. 2021. PMID: 33272175 Review.
Cited by
-
SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights.Int J Mol Sci. 2022 Mar 10;23(6):2986. doi: 10.3390/ijms23062986. Int J Mol Sci. 2022. PMID: 35328409 Free PMC article.
-
Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.BioDrugs. 2023 Sep;37(5):649-674. doi: 10.1007/s40259-023-00611-8. Epub 2023 Jul 18. BioDrugs. 2023. PMID: 37464099 Review.
-
Utilizing genomic signatures to gain insights into the dynamics of SARS-CoV-2 through Machine and Deep Learning techniques.BMC Bioinformatics. 2024 Mar 27;25(1):131. doi: 10.1186/s12859-024-05648-2. BMC Bioinformatics. 2024. PMID: 38539073 Free PMC article.
-
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants.Viruses. 2024 Jun 1;16(6):900. doi: 10.3390/v16060900. Viruses. 2024. PMID: 38932192 Free PMC article. Review.
-
A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug.Cell Death Dis. 2024 Jun 28;15(6):458. doi: 10.1038/s41419-024-06802-7. Cell Death Dis. 2024. PMID: 38937437 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous